Related Experiment Video

Updated: Sep 21, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 25, 2010

20.1K

Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation

Jindrich Cinatl1, Martin Scholz, Hans Wilhelm Doerr

  • 1Interdisziplinäres Labor für Tumor- und Virusforschung, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany. cinatl@em.uni-frankfurt.de

Medicinal Research Reviews
|September 25, 2004
PubMed

Insights

Cytomegalovirus (CMV) evades immune surveillance. This review explores how CMV may also hinder anti-tumor immunity, impacting cancer progression and oncomodulation.

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Cytomegalovirus (CMV) possesses known immune evasion mechanisms for persistence.
  • Previous research focused on CMV's escape from host immune surveillance.
  • The impact of CMV on anti-tumor immune responses remains largely unexplored.

Purpose of the Study:

  • To review current knowledge on CMV's role in tumor immune escape.
  • To investigate CMV-mediated oncomodulation and its effect on cancer progression.
  • To propose new insights into CMV-associated tumor development.

Main Methods:

  • Literature review of recent studies on CMV and cancer.
  • Analysis of molecular mechanisms of CMV immune evasion in tumors.
  • Synthesis of findings on CMV's influence on anti-tumor immunity.

Main Results:

  • CMV employs strategies to evade host immune surveillance.
  • Evidence suggests CMV can modulate the tumor microenvironment.
  • CMV may impair immune responses crucial for tumor cell elimination.

Conclusions:

  • CMV infection might contribute to tumor progression through immune modulation.
  • Understanding CMV's oncomodulatory effects is critical for cancer research.
  • Further investigation is needed to elucidate CMV's impact on cancer immunity and development.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 6, 2019

10.1K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 6, 2025

1.4K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...